Pulmonary Arterial Hypertension Drug OK'd by Europe

, the Europe an Medicines Agency's Committee for Medicinal Products for Human Use gave Winrevair a positive opinion for the treatment of patients with

Winrevair, in combination with other PAH therapies, is indicated for the treatment of PAH in adult patients with World Health Organization functional class II-III, to improve exercise capacity. The positive opinion means that the first-in-class medicine has been recommended for the granting of a marketing authorization in the European Union to treat adult patients with PAH, in combination with other specific PAH therapies, to improve exercise capacity.Winrevair is a human recombinant fusion protein. It comprises the extracellular domain of the activin receptor type IIA attached to the Fc domain of human immunoglobulin G1.

PAH - Pulmonary Arterial Hypertension PAH Pulmonary Hypertension Drug/Treatment Safety Drug Safety Treatment Safety Drug Regulation Drug Registries Drug Registry Drug Legislation Drug Development Drug Discovery Drug Pipeline Drug Development Pipeline Europe European Exercise Physical Activity Hypertension Increased Blood Pressure Blood Clinical Research

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Salt Lake man previously arrested in big drug bust faces new drug chargesA Salt Lake man arrested several years ago during a big drug bust in Cottonwood Heights is facing new charges of operating a drug lab.
Source: KSLcom - 🏆 549. / 51 Read more »

San Francisco officials push for drug-free housing in reversal of 'drug-permissive' policies: ReportLawmakers in San Francisco announced plans Monday to introduce legislation that would allow some state funds to go towards “drug-free' housing.
Source: FoxNews - 🏆 9. / 87 Read more »

Lanthanide nanohybrids show promise in treating pulmonary biofilm infectionsBacterial biofilm infections are among the leading causes of morbidity and mortality among patients with cystic fibrosis or those with weakened immune systems. Treatment for biofilm infections usually entails intensive antibiotic therapy.
Source: physorg_com - 🏆 388. / 55 Read more »

Why Are We Undertreating So Many Pulmonary Embolisms?Less than 0.5% of patients with pulmonary embolism are receiving advanced therapies, big data analytics show.
Source: Medscape - 🏆 386. / 55 Read more »

Mechanical Thrombolysis Effective in Pulmonary EmbolismRecently approved by the US Food and Drug Administration, catheter-directed thrombolysis improved heart function and clot burden in patients with acute intermediate-risk embolism, new trial data show.
Source: Medscape - 🏆 386. / 55 Read more »

Adults With Cystic Fibrosis Report Poor Sleep, Fatigue, DepressionSleep quality and other non-pulmonary symptoms were chronic and persistent for up to a year.
Source: Medscape - 🏆 386. / 55 Read more »